Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: stroke risk

sentinel cerebral protection device capturing embolic debris

More Evidence That Embolic Protection Reduces Disabling Stroke Risk During TAVR

Analysis of STS/ACC TVT Registry finds greatest benefit in patients with prior stroke

23-CNR-3938585-CQD-Hero-650×450 Dr Caimi1
July 13, 2023/Cancer/Research

Increased Risk of Stroke, Bleeding and Atrial Fibrillation in Older CLL Patients Treated with Ibrutinib

Regular surveillance necessary to identify safety signals

Boston Scientific Corporation WATCHMAN FLX Device

Watchman FLX at 1 Year: Real-World Performance Consistent With Trial Results

Large SURPASS registry study confirms high seal rates, acceptable safety

22-HVI-3167284_stroke-in-brain_650x450

Is It Time to Add ‘C’ for Cancer to the CHA2DS2 VASc Score?

Large data analysis finds cancer helps predict stroke risk in patients with atrial fibrillation

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-HVI-3221311 CQD 650×450

PROTECTED TAVR Finds Reduced Rate of Disabling Stroke With Cerebral Embolic Protection

Results from largest randomized trial of the technology to date

The Featured Image for the post

SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days

Interim report from large registry analysis compares favorably with pivotal trial

20-NEU-063-stroke-epidemiology-650×450
February 20, 2020/Neurosciences/Research

Exploring U.S. Stroke Epidemiology Across Demographic and Urban-Rural Divides

Database studies find risks related to race, insurance type, geography

BackPage 1 of 1Next

Advertisement

Ad